BR0315555A - Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais - Google Patents

Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais

Info

Publication number
BR0315555A
BR0315555A BR0315555-2A BR0315555A BR0315555A BR 0315555 A BR0315555 A BR 0315555A BR 0315555 A BR0315555 A BR 0315555A BR 0315555 A BR0315555 A BR 0315555A
Authority
BR
Brazil
Prior art keywords
proteins
production
egm
vectors
transforming
Prior art date
Application number
BR0315555-2A
Other languages
English (en)
Inventor
Jorge Roberto Toledo Alonso
Oliberto Sanchez Ramos
Maria Pilar Rodriguez Molto
Fidel Ovidio Castro Reboredo
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of BR0315555A publication Critical patent/BR0315555A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/102—Caprine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

" MéTODO PARA A PRODUçãO DE PROTEìNAS HETERóLOGAS NO LEITE DE MAMìFEROS NãO HUMANOS MEDIANTE A TRANSFORMAçãO DO EGM COM VETORES ADENOVIRAIS". Método que permite a produção de proteínas de interesse biofarmacêutico a partir da glândula mamária de animais não transgênicos. Os genes que codificam para referidas proteínas são transferidos para as células epiteliais mamárias empregando-se vetores adenovirais. Tais vetores podem basear-se em adenovírus com replicação defectiva, como o <30>E1<30>E3, ou em adenovírus dependentes de ajudante de que se eliminou todas ou quase todas as seq³ências codificantes adenovirais secundárias. Mediante este método é possível a produção de altos níveis de proteínas recombinantes no leite, permitindo desta forma a produção em grande escala de proteínas de interesse biofarmacêutico em sua forma biologicamente ativa.
BR0315555-2A 2002-10-21 2003-10-20 Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais BR0315555A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
PCT/CU2003/000011 WO2004034780A2 (es) 2002-10-21 2003-10-20 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Publications (1)

Publication Number Publication Date
BR0315555A true BR0315555A (pt) 2005-08-23

Family

ID=40134844

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315555-2A BR0315555A (pt) 2002-10-21 2003-10-20 Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais

Country Status (13)

Country Link
EP (1) EP1557084A2 (pt)
JP (1) JP2006503560A (pt)
KR (1) KR20050083791A (pt)
CN (1) CN1744814A (pt)
AR (1) AR041644A1 (pt)
AU (1) AU2003273726B8 (pt)
BR (1) BR0315555A (pt)
CA (1) CA2502902A1 (pt)
CU (1) CU23102A1 (pt)
MX (1) MXPA05004295A (pt)
RU (1) RU2345088C2 (pt)
WO (1) WO2004034780A2 (pt)
ZA (1) ZA200503166B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23576A1 (es) * 2006-02-28 2010-09-30 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la influenza aviar
CU23544A1 (es) * 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
CN1869217B (zh) * 2006-05-22 2013-08-07 李青旺 以腺病毒为载体乳腺表达生产转基因蛋白药物的方法
US9738694B2 (en) 2008-06-30 2017-08-22 Cho-A Pharm. Co., Ltd. Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
KR20140132706A (ko) * 2011-12-19 2014-11-18 엘에프비 유에스에이, 인크. 염증성 장애의 치료를 위한 재조합 인간 알파-1-안티트립신
CL2014002410A1 (es) * 2014-09-12 2014-11-14 Univ Concepcion Método para la producción de proteínas recombinantes en glándula mamaria de mamíferos mediante la transformación del epítelio glandular mamario con vectores adenoasociados.
WO2018085967A1 (en) * 2016-11-08 2018-05-17 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Genetically humanized mammals expressing human serum albumin and uses thereof
ES2980492T3 (es) 2019-07-25 2024-10-01 Medichem S A Procedimiento para la síntesis de N-alquil-4-piridinaminas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780009A (en) * 1995-01-20 1998-07-14 Nexia Biotechnologies, Inc. Direct gene transfer into the ruminant mammary gland
AU7719596A (en) * 1995-11-07 1997-05-29 Baylor College Of Medicine Adenovirus-mediated production of bioactive proteins by mammalian cells and animals
EP0954579A1 (en) * 1996-06-20 1999-11-10 Merck & Co., Inc. Gene therapy for obesity
WO1999043795A1 (en) * 1998-02-24 1999-09-02 Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada Trans-somatics with gene transfer into mammary epithelial cells
WO2002034282A2 (en) * 2000-10-27 2002-05-02 Beth Israel Deaconess Medical Center, Inc. Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis

Also Published As

Publication number Publication date
JP2006503560A (ja) 2006-02-02
KR20050083791A (ko) 2005-08-26
AU2003273726B2 (en) 2009-07-09
RU2005115495A (ru) 2005-11-20
AU2003273726B8 (en) 2009-09-03
WO2004034780A3 (es) 2004-05-27
ZA200503166B (en) 2006-10-25
RU2345088C2 (ru) 2009-01-27
CN1744814A (zh) 2006-03-08
CU23102A1 (es) 2005-12-20
WO2004034780A2 (es) 2004-04-29
MXPA05004295A (es) 2005-08-03
AU2003273726A1 (en) 2004-05-04
CA2502902A1 (en) 2004-04-29
AR041644A1 (es) 2005-05-26
EP1557084A2 (en) 2005-07-27

Similar Documents

Publication Publication Date Title
Fidler et al. Collagen IV and basement membrane at the evolutionary dawn of metazoan tissues
Vedula et al. Diverse functions of homologous actin isoforms are defined by their nucleotide, rather than their amino acid sequence
Ain et al. A prolactin family paralog regulates reproductive adaptations to a physiological stressor
Burgess et al. AP-1 and clathrin are essential for secretory granule biogenesis in Drosophila
Alzahofi et al. Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteins
NZ514951A (en) Recombinant protein production in a cultured human cell
RU2012118381A (ru) Создание гаплоидных растений и усовершенствование селекции растений
BR0315555A (pt) Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais
Alvares The role of acidic phosphoproteins in biomineralization
Bettegowda et al. JY-1, an oocyte-specific gene, regulates granulosa cell function and early embryonic development in cattle
Pirottin et al. Transgenic engineering of male-specific muscular hypertrophy
Tikhonenko et al. A kinesin-mediated mechanism that couples centrosomes to nuclei
Shi et al. Tβ4-overexpression based on the piggyBac transposon system in cashmere goats alters hair fiber characteristics
Zhang et al. Mutation of cyp19a1b results in sterile males due to efferent duct obstruction in Nile tilapia
You et al. CRISPR/Cas9-mediated specific integration of Fat-1 and IGF-1 at the p Rosa26 locus
Wang et al. Functional analysis of the promoter region of Japanese flounder (Paralichthys olivaceus) β-actin gene: a useful tool for gene research in marine fish
Wang et al. Efficient generation of GHR knockout Bama minipig fibroblast cells using CRISPR/Cas9-mediated gene editing
RU2009131929A (ru) Применение интрона-1 гена бета-актина курицы
ATE546531T1 (de) Transaktivierungssystem für säugerzellen
Li et al. Efficient generation of P53 biallelic mutations in diannan miniature pigs using RNA-guided base editing
WO2009145606A8 (en) Method for the production of proteins or protein fragments
Blechman et al. Genome editing reveals idiosyncrasy of CNGA2 ion channel-directed antibody immunoreactivity toward oxytocin
Yuan et al. Generation of mice encoding a conditional null allele of Gcm2
Kim et al. Gadd45-induced cell cycle G2/M arrest for improved transient gene expression in Chinese hamster ovary cells
Yang et al. High level expression of recombinant human antithrombin in the mammary gland of rabbits by adenoviral vectors infection

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.